Viewing Study NCT03505320


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2025-12-26 @ 3:15 AM
Study NCT ID: NCT03505320
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2018-03-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module